Orthofix Medical Inc. (DE) (OFIX) Peer Comparison

$8.88

$-0.03 (-0.34%)

As on 10-Sep-2026 10:35EDT

Market cap

$376 Mln

Revenue (TTM)

$833 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Edit

	Orthofix Medical Inc. (DE) (OFIX)	Penumbra (PEN)	Glaukos Corp (GKOS)	Bio-Rad Laboratories	Repligen (RGEN)
Market cap ($ Mln)	376	12,650	10,638	9,762	9,459
Revenue ($ Mln)	833	1,505	613	2,589	785
Net Profit ($ Mln)	-61.72	160.59	-188.05	222.40	41.54
Net Margin (%)	-7.41	10.67	-30.68	8.59	5.29
RoE (%)	-14.04	10.86	-28.10	3.04	1.97
Price to Earnings	--	79.29	--	44.47	232.78
Price-To-Book	0.89	8.31	15.27	1.36	4.62

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Orthofix Medical Inc. (DE) (OFIX)	Penumbra (PEN)	Glaukos Corp (GKOS)	Bio-Rad Laboratories	Repligen (RGEN)
Operating Revenue	833.19	1,504.87	612.84	2,589.30	785.10
Cost of Revenue	253.38	483.98	127.96	1,245.50	384.30
Gross Profit	551.71	942.44	393.22	1,343.60	347.62
Operating Expenses	605.22	833.56	565.37	1,108.90	335.50
Operating Profit (EBIT)	-25.42	187.34	-80.49	235.00	65.30
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-60.29	203.83	-192.83	350.40	52.15
Provision for Tax	1.44	43.24	-4.79	128.00	10.61
Profit after Tax (Net Income)	-61.72	160.59	-188.05	222.40	41.54
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	93.19	0.00	0.00	0.00

Liabilities ($ Mln)

	Orthofix Medical Inc. (DE) (OFIX)	Penumbra (PEN)	Glaukos Corp (GKOS)	Bio-Rad Laboratories	Repligen (RGEN)
Shareholder's Funds	429.18	1,530.77	682.49	7,173.90	2,112.03
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	286.83	210.18	135.71	2,116.80	705.49
Current Liabilities	157.01	233.78	102.33	961.30	132.66
Total Liabilities	850.65	1,826.52	893.49	10,576.50	2,949.70

Assets ($ Mln)

	Orthofix Medical Inc. (DE) (OFIX)	Penumbra (PEN)	Glaukos Corp (GKOS)	Bio-Rad Laboratories	Repligen (RGEN)
Non-Current Assets	426.89	630.60	404.74	7,231.50	1,749.63
Current Assets	446.13	1,344.12	515.78	3,020.50	1,200.55
Total Assets	850.65	1,826.52	893.49	10,576.50	2,949.70
Total Debt*	234.62	212.71	102.84	1,203.70	690.94
Net Current Assets	289.12	1,110.35	413.45	2,059.20	1,067.90

Cashflow ($ Mln)

	Orthofix Medical Inc. (DE) (OFIX)	Penumbra (PEN)	Glaukos Corp (GKOS)	Bio-Rad Laboratories	Repligen (RGEN)
Cash From Operating Activities	33.35	238.66	-46.34	532.20	117.42
Cash Flow from Investing Activities	-34.60	-404.59	-77.61	-189.70	-298.47
Cash from Financing Activities	-0.79	26.53	11.89	-283.20	-15.21
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Orthofix Medical Inc. (DE) (OFIX)	Penumbra (PEN)	Glaukos Corp (GKOS)	Bio-Rad Laboratories	Repligen (RGEN)
ROCE (%)	-13.54	11.76	-22.53	8.98	1.79
ROE (%)	-14.04	10.86	-28.10	3.04	1.97
ROA (%)	-6.12	7.95	-18.00	2.02	1.36
EBIT Margin (%)	-4.55	13.63	-30.58	-5.99	9.87
Net Margin (%)	-7.41	10.67	-30.68	8.59	5.29
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Orthofix Medical Inc. (DE) (OFIX)	Penumbra (PEN)	Glaukos Corp (GKOS)	Bio-Rad Laboratories	Repligen (RGEN)
Revenue Growth (%)	2.99	17.55	41.55	1.37	16.49
EBIT Growth (%)	59.68	17.49	-116.42	-131.06	920.91
Net Profit Growth (%)	50.11	8.72	-102.66	-30.32	400.42
EPS Growth (%)	51.76	8.12	-96.88	-29.66	394.30
Book Value Growth (%)	-9.58	17.33	-12.65	2.19	2.16

Valuation Ratios

	Orthofix Medical Inc. (DE) (OFIX)	Penumbra (PEN)	Glaukos Corp (GKOS)	Bio-Rad Laboratories	Repligen (RGEN)
Price / Earnings	-6.58	68.93	-34.59	--	189.42
Price / Book Value	1.35	8.58	9.90	--	4.40
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-33.72	53.25	-43.50	--	55.90
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Orthofix Medical Inc. (DE) (OFIX)	Penumbra (PEN)	Glaukos Corp (GKOS)	Bio-Rad Laboratories	Repligen (RGEN)
Debt to Equity	0.52	0.00	0.00	0.11	0.26
Short term debt to equity ratio	0.00	0.01	0.00	0.06	0.01
Current Ratio	2.84	5.75	5.04	3.14	9.05
Quick Ratio	1.67	3.86	4.46	2.33	7.64
Interest Coverage	-1.90	157.91	-38.31	8.18	1.92

Operating Efficiency Ratios

	Orthofix Medical Inc. (DE) (OFIX)	Penumbra (PEN)	Glaukos Corp (GKOS)	Bio-Rad Laboratories	Repligen (RGEN)
Debtors to sales (%)	16.30	12.65	22.67	17.06	20.09
Asset Turnover	0.83	0.74	0.59	0.24	0.26
Receivable days	60.07	46.54	60.95	65.39	72.41
Inventory Days	150.91	331.92	193.84	221.09	146.53
Payable days	72.34	26.16	60.19	37.02	29.05
Cash Conversion Cycle	138.64	352.30	194.60	249.46	189.88

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly